-

ŌURA Announces Confidential Submission of Draft Registration Statement for Proposed Initial Public Offering

SAN FRANCISCO--(BUSINESS WIRE)--Oura Inc. today announced that it has confidentially submitted a draft registration statement on Form S-1 with the Securities and Exchange Commission (the “SEC”) relating to the proposed initial public offering of its common stock. The number of shares to be offered and the price range for the proposed offering have not yet been determined. The initial public offering is expected to take place after the SEC completes its review process, subject to market and other conditions.

This press release does not constitute an offer to sell or the solicitation of an offer to buy any securities. Any offers, solicitations of offers to buy, or any sales of securities will be made in accordance with the registration requirements of the Securities Act of 1933, as amended (the “Securities Act”). This press release is being issued in accordance with Rule 135 under the Securities Act.

About ŌURA

ŌURA delivers personalized health data, insights, and daily guidance with Oura Ring, the leading smart ring that helps you live healthier, longer. Guided by a mission to shift healthcare from sick care to prevention, Oura supports millions of members worldwide across sleep, activity, stress, readiness, women’s health, and heart health. Scientifically validated against medical gold standards, the lightweight Oura Ring tracks 50+ health metrics continuously, empowering both individuals and thousands of research teams, healthcare providers, and organizations. With 1,200+ partners across wellness and medicine, Oura is advancing the future of preventative health.

Founded in Finland in 2013, ŌURA is headquartered in San Francisco with E.U. headquarters in Oulu, Finland.

Oura Ring is not a medical device and is not intended to diagnose, treat, cure, monitor, or prevent medical conditions or illnesses.

Oura Inc.


Release Versions

More News From Oura Inc.

Oura Releases 2026 Annual Healthcare Report 

SAN FRANCISCO--(BUSINESS WIRE)--ŌURA, a health intelligence platform and maker of the world’s smallest smart ring, released its 2026 Annual Healthcare Report. Earlier Insights, More Informed Care: Oura’s Impact Across Payer Priorities examines how payers and health plans can build on continuous, personalized health insights to strengthen member engagement and extend support beyond traditional healthcare visits.Members wear Oura Ring an average of 23.5 hours a day, and 85% stay with Oura for a ye...

Oura to Acquire Counsel Health, Advancing Vision for More Connected, Personalized Healthcare

SAN FRANCISCO--(BUSINESS WIRE)--ŌURA, a leading health intelligence platform and maker of the world’s smallest smart ring, has entered into a definitive agreement to acquire Counsel Health, an AI-native primary care company. Founded and built by physicians and AI researchers, Counsel combines medical AI with in-house physicians to deliver immediate, high-quality guidance and care. By pairing Oura’s continuous biometric data with Counsel’s platform and on-demand human doctors, Oura Members recei...

ŌURA Expands Healthcare Research With First Clinical Trial Exploring GLP-1 Treatment Outcomes

SAN FRANCISCO--(BUSINESS WIRE)--ŌURA, a health intelligence platform and maker of the world’s smallest smart ring, today announced the launch of SMART-BMI, its first clinical trial, in collaboration with UC San Diego Health, examining outcomes from GLP-1 treatment and bariatric surgery. The multi-year study is the latest addition to Oura’s growing work in healthcare research, scientific validation, and outcomes measurement, led by the Office of Regulatory and Clinical Affairs (ORCA), which was...
Back to Newsroom